University of agribusiness and rural development, UARD Jubilee International Scientific Conference

Font Size: 
The Location of the Cytoplasm in the Prevention of Cervical Cancer
Valentin Irmov, Petar Petrov

Last modified: 2018-02-12


A very small proportion of respondents have been doing five or more cytotoxic scans in the last five years, which is the WHO's real recommended behavior. A major factor influencing the incidence of cytotoxic smears according to our study is the social status of the respondents. Another factor influencing the research indicator is the ethnicity of the respondents. Age and education of respondents also influence their attitudes about the frequency of cytotoxic masks. Most of the respondents are of the opinion that they should be cycling on an annual basis.


cytoplasm, prevention, education.


  1. Alvarez EA, Brady WE, Walker JL, et al. Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2013 Apr;129(1):22-7. Epub 2012 Dec 20.
  2. Bray, F., et al., Endometrial cancer incidence trends in Europe: underlying determinants and prospects for prevention. Cancer Epidemiol Biomarkers Prev, 2005. 14(5): p. 1132-[26]Beining RM, Dennis LK, Smith EM, Dokras A. Meta-analysis of intrauterine device use and risk of endometrial cancer. Ann Epidemiol. 2008;18:492-499.
  3. Cardenes HR, Look K, Michael H, Cerezo L. Endometrium. In: Halperin EC, Perez CA,
  4. Brady LW, eds. Perez and Brady's Principles and Practice of Radiation Oncology. 5th ed. Philadelphia, Pa: Lippincott Williams and Wilkins; 2008: 1610-1628.
  5. European age-standardised rates calculated by the Statistical Information Team at Cancer Research UK. 2011, using data from GLOBOCAN 2008, v1.2, IARC.
  6. Evans JM, Donnelly LA, Emslie-Smith AM, et al. Metformin and reduced risk of cancer in diabetic patients. BMJ. 2005;330:1304–1305.
  7. Dalvi TB, Canchola AJ, Horn-Ross PL. Dietary patterns, Mediterranean diet, and endometrial cancer risk. Cancer causes & control: CCC. Nov 2007;18(9):957-966.
  8. European age-standardised rates calculated by the Statistical Information Team at Cancer Research UK. 2011, using data from GLOBOCAN 2008, v1.2, IARC.
  9. Jick H, Walker AM, Rothman KJ. The epidemic of endometrial cancer: a commentary. Am J Public Health. 1980 Mar;70(3):264-7.
  10. Nout RA, Smit VT, Putter H, et al. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. Lancet. 2010 Mar 6;375(9717):816-23.
  11. Nussler NC, Reinbacher K, Shanny N, et al. Sex-specific differences in the expression levels of estrogen receptor subtypes in coloectal cancer. Gend Med. 2008 Sep;5(3):209-17.
  12. Odagiri T, Watari H, Hosaka M, Mitamura T, Konno Y, Kato T. Sakuragi N. Multivariate survival analysis of the patients with recurrent endometrial cancer. J Gynecol Oncol. Mar 31 2011;22(1):3-8.


Full Text: PDF